id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2257-0006,FDA,FDA-2020-E-2257,Determination of Regulatory Review Period for Purposes of Patent Extension; XCOPRI,Notice,Determinations,2022-11-09T05:00:00Z,2022,11,2022-11-09T05:00:00Z,2023-01-10T04:59:59Z,2022-11-10T02:00:38Z,2022-24457,0,0,090000648549d5cd
FDA-2020-E-2257-0005,FDA,FDA-2020-E-2257,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T19:04:08Z,,0,0,09000064852d0f6e